Skip to main content

Most Popular

2022 EULAR Recommendations for ANCA-associated Vasculitis

Mar 16, 2023

EULAR has published the 2022 update on recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Read Article

Does Biologic Treatment in Psoriasis Reduce the Risk of Psoriatic Arthritis?

Mar 07, 2023

Retrospective claims analysis shows that psoriasis patients treated with either an IL-12/23 inhibitor or an IL-23 inhibitor had a lower risk of developing incident psoriatic arthritis, compared to TNF inhibitors or IL-17 inhibitors.

Read Article

Our old friend, hydroxychloroquine

Mar 22, 2023

After an action packed weekend, RheumNow Live 2023 concluded on Sunday with a half-day session on systemic lupus erythematous and ankylosing spondylitis discussing many new medications that are revolutionizing rheumatology. Dr.

Read Article

Cost-Effective Use of Biological and Targeted Synthetic DMARDs

Mar 14, 2023

An international task force of 13 European experts have developed evidence-based points to consider regarding the cost-effective use of biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in the treatment of inflammatory rheumatic diseases (including rheumatoid ar

Read Article

Treat-to-Target Guidelines for GCA and PMR

Feb 28, 2023

The Annals of Rheumatic Disease has published updated multinational, treat-to-target (T2T) recommendations for the treatment of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).

Read Article

Big Time Vasculitis (3.10.2023)

Mar 10, 2023

Dr. Jack Cush Reviews the News and Journal articles from the past week on RheumNow. This weeks highlights includes insights on scleroderma, myositis, vasculitis and answers the question - does aggressive biologic treatment of psoriasis prevent future psoriatic arthritis?

Read Article

NSAIDs in Pregnancy (3.3.2023)

Mar 03, 2023

Dr. Jack Cush reviews the lastest journal articles, news, and FDA announcements from the past week on RheumNow.  This week, the importance of IFNa, Subclinical PsA and NSAID safety during Pregnancy.

Read Article

A Pilot Trial of Anifrolumab in Discoid Lupus

Mar 15, 2023

A research report in JAMA Dermatology describes the use of the type 1 interferon receptor inhibitor anifrolumab in patients with chronic discoid lupus erythematosus (DLE). 

Read Article

Renal Involvement is Pivotal in ANCA-Associated Vasculitis

MedPage Today
Mar 06, 2023

Bearing in mind that renal impairment is among the worst complications of ANCA-associated vasculitis (AAV), researchers have identified four different trajectories of kidney function over time in AAV patients, with implications for personalized treatment, as well as future research.

Read Article

Phase 3 Trials of Baricitinib Disappoint in SLE

Feb 27, 2023

Despite the encouraging phase II trial results of baricitinib in systemic lupus erythematosus (SLE) patients, two parallel phase III trials have failed to redemonstrate the efficacy of baricitinib in active SLE, thereby halting development of baricitinib in SLE. 

Read Article

Carpal Tunnel - Steroid injection vs. Night Splinting

Mar 13, 2023

A prospective, pragmatic, open-label, randomized trial conducted by the UK National Health Service, studied interventions in patients with carpal tunnel syndrome (CTS) and found no advantage to either CTS corticosteroid injection (CSI) or night splinting (NS) as the initial treatment of CTS.

Read Article

Spondyloarthritis Innovations

Mar 21, 2023

The second day of RheumNow Li

Read Article

Long-Term Benefit of Rituximab in Systemic Sclerosis

Mar 06, 2023

A small cohort trial of rituximab (RTX) in 29 systemic sclerosis patients showed significantly improved skin sclerosis and lung function after a follow-up of 96 weeks.

Read Article

VEGA - The Efficacy of Combination Biologics in Ulcerative Colitis

Mar 02, 2023

A novel trial has shown that combination biologic therapy (guselkumab plus golimumab) to be more effective in ulcerative colitis than either biologic alone.

Read Article

Psoriatic Arthritis: Depressing News on Second- and Later-Line Treatments

MedPage Today
Feb 28, 2023

Most patients with psoriatic arthritis (PsA) failed to achieve low disease activity after switching from one targeted therapy to another, real-world data from Scandinavian registries indicated.

Read Article

Tofacitinib May Reduce Interstitial Lung Disease Risk in RA

MedPage Today
Mar 23, 2023

Tofacitinib (Xeljanz) in patients with rheumatoid arthritis (RA) stood out among several other biologic and targeted synthetic disease-modifying antirheumatic drugs (sDMARDs) when it came to the incidence of interstitial lung disease (ILD), a retrospective cohort study showed.

Read Article

Long-Term Survival of Idiopathic Inflammatory Myopathies

Mar 09, 2023

A single center cohort study analyzed the outcome and survival of idiopathic inflammatory myositis (IIM) patients and showed good 5 and 10 year survival but showed significant declined 15-25 years post-diagnosis.

Read Article

Marathon Running Not a Risk Factor for Arthritis

MedPage Today
Mar 13, 2023

Intensity of distance running had no bearing on the prevalence of hip and knee osteoarthritis among participants in recent editions of the Chicago Marathon, researchers reported here.

Read Article

What to do about pre-clinical RA?

Mar 20, 2023

Much like the recent ACR Convergence, RheumNow Live’s 2023 conference led with this year’s hot topic of rheumatoid arthritis and especially what to do regarding pre-clinical RA.

Read Article
×